We promote the understanding of assessment and access processes for life science products to support the development and adoption of innovative treatments
Ukraine has advanced a draft 2027 budget providing UAH21.7 billion for Affordable Medicines and UAH20.8 billion for centralised medicine and medical-device purchasing.
Italy proposes a three-year early-access programme for serious conditions without satisfactory treatment alternatives, funded from the existing Innovative Medicines Fund.